Comparative study of the effectiveness of intra-articular injection of methylprednisolone at doses of 20 and 40 mg in patients with mild shoulder injury

Comparative study of the effectiveness of intra-articular injection of methylprednisolone at doses of 20 and 40 mg in patients aged 20 to 60 years with mild rotator cuff injury

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20130812014333N187

Enrollment

Registered

2022-06-19

Start date

2022-07-06

Completion date

Unknown

Last updated

2022-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

rotator cuff tendinitis. Unspecified injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

Interventions

Intervention 1: In the first intervention group, patients will receive 40 mg of methylprednisolone by intra-articular injection. Intervention 2: In the second intervention group, patients will receive

Eligibility

Sex/Gender

All

Age

20 Years to 60 Years

Inclusion criteria

Inclusion criteria: Patients aged 20 to 60 years Detection of rotator cuff rupture to the extent of tendinosis

Exclusion criteria

Exclusion criteria: Patients with more severe tears than tendinosis; history of fractures Frozen shoulder History of surgery History of previous shoulder injections Patients treated with oral or systemic injectable steroids Concurrent lipoma or DJD joint injuries or concomitant shoulder instabilities

Design outcomes

Primary

Measure	Time frame
Shoulder function. Timepoint: The beginning of the study, the third, sixth and twelfth weeks. Method of measurement: Using the UCLA shoulder rating scale.;Intensity of pain. Timepoint: The beginning of the study, the third, sixth and twelfth weeks. Method of measurement: Using visual pain scale (VAS).;Shoulder function limitations. Timepoint: The beginning of the study, the third, sixth and twelfth weeks. Method of measurement: Simple shoulder test.	—

Measure

Time frame

Shoulder function. Timepoint: The beginning of the study, the third, sixth and twelfth weeks. Method of measurement: Using the UCLA shoulder rating scale.;Intensity of pain. Timepoint: The beginning of the study, the third, sixth and twelfth weeks. Method of measurement: Using visual pain scale (VAS).;Shoulder function limitations. Timepoint: The beginning of the study, the third, sixth and twelfth weeks. Method of measurement: Simple shoulder test.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad Mahdi Rajabi

Kermanshah University of Medical Sciences

Mahdirajabi1899@yahoo.com+98 83 3836 7984

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026